| 421 |
Value of vascular endothelial growth factor, nitric oxide and endostatin measurement in follow up of cancer breast patients". |
2013 |
| 422 |
Value of Vascular Endothelial Growth Factor,Nitric Oxide and Endostatin Measurement in Follow up of Cancer Breast Patients |
2013 |
| 423 |
Value of Vascular Endothelial Growth Factor,Nitric Oxide and Endostatin Measurement in Follow up of Cancer Breast Patients |
2013 |
| 424 |
Value of Vascular Endothelial Growth Factor,Nitric Oxide and Endostatin Measurement in Follow up of Cancer Breast Patients |
2013 |
| 425 |
Value of Vascular Endothelial Growth Factor,Nitric Oxide and Endostatin Measurement in Follow up of Cancer Breast Patients |
2013 |
| 426 |
Value of Vascular Endothelial Growth Factor,Nitric Oxide and Endostatin Measurement in Follow up of Cancer Breast Patients |
2013 |
| 427 |
Value of Vascular Endothelial Growth Factor,Nitric Oxide and Endostatin Measurement in Follow up of Cancer Breast Patients |
2013 |
| 428 |
Value of Vascular Endothelial Growth Factor,Nitric Oxide and Endostatin Measurement in Follow up of Cancer Breast Patients |
2013 |
| 429 |
Vitamin D level and Fok-I vitamin D receptor gene polymorphism in Egyptian patients with type-1 diabetes |
2013 |
| 430 |
15.Haemostatic Changes Associated with Thrombosis in Long Term Hemodialysis Treatment. |
2012 |
هل لديك سؤال ؟
